Featured Articles

Why Should I Use Fastin – a Novel...

It is a sad fact of life that many people are overweight – and a lot are not just overweight, but medically classifi...

Articles Directory - Free articles ...

Urinary tract infection, or UTI, is colonization of microorganisms in the urinary tract in such an amount and such a ...

Expert in Pharmaceutical Sciences a...

PhytoMedical continues product expansion and accelerated development of type-2 compound; Company adds FDA-submission/...

Faulding Receives US FDA Approval F...

UNDERDALE, South Australia--(BUSINESS WIRE)--Jan. 5, 1998-- International pharmaceutical and healthcare company, F H ...

COMPUTER CITY OPENS FIVE LOCATIONS;...

FORT WORTH, Texas--(BUSINESS WIRE)-- May 30, 1995--Computer City(R), North America's preeminent computer superstore re...

FIND A DRUG

Pharmacy Locator

ZIP Distance

Use this tool to find
pharmacies in your area

IN BRIEF. - Free Online Library

Back

VALLEY INDEX FALLS: The Daily News/Bloomberg Index fell 0.05 to 117.37, led by Westlake Village's Dole Food Co. and Wellpoint Health Networks of Woodland Hills. Dole fell $5 to $29.625. Wellpoint fell $2.25 to $62.625.

- Bloomberg News

NURSES ON STRIKE: About 275 registered nurses and other health care workers held a one-day strike at Tarzana Medical Center on Friday to complain about conditions at the hospital and their wages. The workers held a one-day strike Sept. 15, when their labor contract expired. The workers want the hospital to buy devices to help prevent them from contracting blood-borne diseases, the right to file grievances over staffing levels and, chiefly, a raise. Tenet Healthcare, the hospital's owner, is offering workers a 2 percent raise this year and 4 percent next year for senior employees, while more junior employees would receive only 2 percent in 1999.

- City News Service

POWER-ONE OFF: Stock of Camarillo-based Power-One Inc. fell 18 percent by $1.125 to $6.125 Friday after analyst Scott Alaniz at Stephens Inc. downgraded the stock to ``market outperform'' from ``buy'' with a 12-month target price of $7.50. The power-supply producer had reported preadjusted third-quarter earnings Wednesday of $1.2 million, or 7 cents a share, which topped Wall Street estimates.

- Daily News

BAXTER GETS OK: Baxter Healthcare Corp. got approval from the U.S. Food and Drug Administration to manufacture recombinant antihemophilic antihemophilic /an·ti·he·mo·phil·ic/ (-he?mo-fil´ik) counteracting hemophilia, or an agent that so acts. factor at its new Thousand Oaks facility.

The thumbs-up allows Baxter to increase by up to 40 percent its global supply of recombinant factor VIII factor VIII
n.
A factor in the clotting of blood, a deficiency of which is associated with hemophilia A. Also called antihemophilic factor, antihemophilic globulin, antihemophilic globulin A, proserum prothrombin conversion accelerator.
, which is a genetically engineered blood-clotting therapy for hemophilia A victims.

- Daily News